CARMELLINI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 12.670
EU - Europa 11.029
AS - Asia 6.409
SA - Sud America 1.101
AF - Africa 239
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 34
Totale 31.591
Nazione #
US - Stati Uniti d'America 12.508
CN - Cina 2.555
GB - Regno Unito 2.467
SG - Singapore 1.949
RU - Federazione Russa 1.724
IT - Italia 1.529
IE - Irlanda 1.489
UA - Ucraina 1.147
BR - Brasile 925
FR - Francia 796
SE - Svezia 777
DE - Germania 555
HK - Hong Kong 483
VN - Vietnam 438
KR - Corea 384
FI - Finlandia 313
ZA - Sudafrica 146
IN - India 141
BD - Bangladesh 121
CA - Canada 84
ES - Italia 74
AR - Argentina 66
TR - Turchia 50
IQ - Iraq 47
JP - Giappone 40
MX - Messico 39
AU - Australia 27
BE - Belgio 26
NG - Nigeria 25
PK - Pakistan 23
PL - Polonia 21
VE - Venezuela 21
EC - Ecuador 20
UZ - Uzbekistan 19
CO - Colombia 18
MY - Malesia 17
ID - Indonesia 16
KE - Kenya 16
CL - Cile 15
PY - Paraguay 13
RO - Romania 13
NL - Olanda 12
SA - Arabia Saudita 11
AT - Austria 10
JO - Giordania 10
PE - Perù 10
PH - Filippine 10
EU - Europa 9
IL - Israele 9
MA - Marocco 9
NP - Nepal 9
CI - Costa d'Avorio 8
CZ - Repubblica Ceca 8
IR - Iran 8
JM - Giamaica 8
KZ - Kazakistan 8
OM - Oman 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
EG - Egitto 7
HU - Ungheria 7
KG - Kirghizistan 7
LT - Lituania 7
TT - Trinidad e Tobago 7
AZ - Azerbaigian 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
UY - Uruguay 6
AL - Albania 5
CH - Svizzera 5
DZ - Algeria 5
EE - Estonia 5
GR - Grecia 5
LB - Libano 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BH - Bahrain 4
CR - Costa Rica 4
DK - Danimarca 4
KW - Kuwait 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
HN - Honduras 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
SN - Senegal 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
BW - Botswana 2
GT - Guatemala 2
HR - Croazia 2
ME - Montenegro 2
MK - Macedonia 2
PT - Portogallo 2
SC - Seychelles 2
TW - Taiwan 2
VC - Saint Vincent e Grenadine 2
Totale 31.466
Città #
Southend 2.231
Dublin 1.486
Dallas 1.329
Fairfield 1.122
Singapore 987
Chandler 924
Jacksonville 906
Ashburn 861
Milan 541
Hefei 533
Santa Clara 520
Woodbridge 512
Wilmington 483
Beijing 467
Hong Kong 461
Moscow 425
Seoul 379
Seattle 374
Cambridge 361
Houston 355
Nanjing 347
San Jose 336
Ann Arbor 327
Council Bluffs 321
The Dalles 283
Princeton 265
Rome 178
Boardman 175
Lauterbourg 164
Los Angeles 155
Ho Chi Minh City 145
New York 137
Siena 136
Johannesburg 125
Buffalo 113
Nanchang 107
Helsinki 104
Dearborn 92
San Diego 92
Hanoi 87
São Paulo 68
Shenyang 55
Shanghai 54
Tianjin 54
Hebei 51
Bengaluru 50
Madrid 49
Columbus 47
Kunming 46
Munich 41
Figino 39
Jiaxing 39
San Francisco 39
Orem 38
Toronto 38
Jinan 37
Philadelphia 37
Tokyo 37
Changsha 36
Rio de Janeiro 35
London 34
Dong Ket 30
Hangzhou 30
Menlo Park 30
Turin 27
Zhengzhou 26
Brasília 25
Brussels 25
Chicago 24
Naples 23
San Mateo 23
Belo Horizonte 21
Chennai 21
Da Nang 21
Guangzhou 21
Haiphong 21
Dhaka 20
Norwalk 20
Abuja 19
Changchun 19
Atlanta 18
Florence 18
Lancaster 18
Nuremberg 18
Redondo Beach 18
Turku 18
Frankfurt am Main 17
Venezia 17
Bologna 16
Montreal 16
Ningbo 16
Stockholm 16
Sydney 16
Tashkent 16
Baghdad 15
Brooklyn 15
Genoa 15
Kuala Lumpur 15
Manchester 15
Auburn Hills 14
Totale 20.643
Nome #
Andamento longitudinale di biomarkers di infiammazione ed immunoattivazione in pazienti sottoposti a trapianto di rene: un ruolo della replicazione di CMV? 359
Analysis of the IgVH genes in T cell-mediated and antibody-mediated rejection of the kidney graft. 337
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early [vs. delayed] introduction of everolimus in de novo kidney transplant recipients, with a follow-up evaluation at 12 month after transplant (NEVERWOUND study) 312
Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature 305
L'accesso chirurgico all'arteria femorale comune: considerazioni anatomiche in relazione alla profilassi dell'infezione delle protesi arteriose 298
HCMV infection in renal transplant recipients: a retrospective cohort study 290
Monitoring kidney-transplant patients using metabolomics and dynamic modeling 286
Sieroprevalenza di HEV in donatori di sangue e pazienti trapiantati di rene nella provincia di Siena. 273
Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. 270
Using metabolomics to monitor kidney transplantation patients by means of clustering to spot anomalous patient behavior 270
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 269
A randomized study comparing three cyclosporine based regimens in cadaveric renal transplantation: results at 7 years 268
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 265
Bilateral renal cell carcinoma of the native kidneys after renal transplantation 258
Cardiac arrest following intravenous administration of Clindamycin phosphate [Arresto cardiaco indotto dalla somministrazione endovenosa di clindamicina fosfato. Descrizione di un caso clinico] 248
SIEROPREVALENZA DI HEV IN UNA COORTE DI PAZIENTI CANDIDATI A TRAPIANTO RENALE 246
Conversion of stable kidney transplant recipients from a twice-daily to once-daily everolimus regimen. 246
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 244
A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine 239
Establishment and characterization of murine small cell lung carcinoma cell lines derived from HPV-16 E6/E7 transgenic mice. 238
Cytomegalovirus infection with multiple colonic perforations in a renal transplant recipient 233
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? 229
Acute Ciclosporin Nephrotoxicity in Renal Transplant Patients 227
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation 226
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients 225
A randomized study comparing Cyclosporine alone vs double and triple therapy in renal transplants 222
ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus 221
Massive hemothorax after removal of subclavian vein catheter: a very unusual complication 219
Immediate Introduction of Everolimus Does Not Affect Wound Healing and Delayed Graft Function in Renal Transplant Patients: Preliminary Results From NEVERWOUND Study 216
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine 212
99mTc-DTPA scintigraphy in renal allograft rejection 209
Calcineurin-inhibitor induced pain syndrome after organ transplantation. 208
Rejection in Liver Allograft Recipients: Clinical Characterization and Management 206
A Randomized Study Comparing Three Cyclosporine-Based Regimens in Cadaveric Renal Transplantation 202
Transplantation of bovine pancreatic islets into the thymus of nonimmunosuppressed pigs 198
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 198
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey 197
Acute Changes in Serum CEA Induced by Surgery in Colorectal Cancer Patients 196
A study of pig kidneys to expand organ pool 195
Standardized psychological evaluation pre and post transplantation: a new option 193
Confronto tra duplice e triplice terapia immunosoppressiva nel trapianto di rene da cadavere. Studio retrospettivo 192
Association of clinical events with everolimus exposure in kidney transplant patients receiving reduced cyclosporine 191
Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation 188
Pancreatic glucagon damages isolated human islet function 187
Diagnosis and approach to posttransplant diabetes. 187
Renal transplant from very old donors: how far can we go? 184
Hepatocyte grafting as an alternative to liver transplant 184
Efficacy of everolimus with reduced-exposure cyclosporine in de novo kidney transplant patients at increased risk for efficacy events: analysis of a randomized trial 184
Laparoscopic nephrectomy for massive kidneys in polycystic kidney disease 184
Generalized lymphedema in a sirolimus-treated renal transplant patient 183
Mycophenolate Mofetil/Neoral/Steroid vs Neoral/Steroid therapy for prophylaxis of acute rejection in renal transplant recipients 183
Renal transplantation following reduction of ileocecocystoplasty performed 9 years earlier for undiversion 183
Imipenem/Cilastatin reduces cyclosporin-induced tubular damage in kidney transplant recipients 182
Il ruolo dell'infezione da CMV e del suo monitoraggio attivo nella nuova era dei trapianti di rene: risultati di una coorte completa 182
Acute effects of peritoneousvenous shunt on the hemodynamics and gas exchange in patients with hepatic intractable ascites 181
Conversion of Stable Kidney Transplant Recipients from a Twice-Daily Everolimus Regimen to a Once-Daily Everolimus Regimen. 181
Kidney transplantation from donors aged 65 years or more as single or dual grafts 181
Effect of kidney transplantation on quality of life measures 180
Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome 180
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results 180
Long-term outcome of renal transplantation from marginal donors 177
Activated coagulation time for the assessment of heparin-induced anticoagulation in peripheral vascular surgery [Il tempo di coagulazione attivato per la valutazione dell'anticoagulazione da eparina nella chirurgia vascolare periferica] 176
Xenotransplantation of bovine islets into the thymus of totally pancreatectomized pigs 175
Role of Ultrasound in Renal Transplantation 174
Preparation and long-term culture of isolated human pancreatic islets 173
Uso dell'emodiluizione normovolemica in chirurgia vascolare: prevenzione dell'edema e della trombosi venosa post-operatoria 172
Effects of glibenclamide and metformin (alone or in combination) on insulin release from isolated human pancreatic islets 170
safe conversion of stable kidney transplant recipients from twice-daily tacrolimus (Prograf) to once-daily modified release tacrolimus (advagraf) 170
Serum CEA monitoring in the follow up of colorectal cancer patients with negative preoperative serum CEA 169
Transplantation of purified bovine islets into the thymus of non-immunosuppressed pigs 168
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study 168
Effect of immunosuppressive regimens on neutrophil chemotaxis 167
Causes and effects of delayed graft function in cadaveric renal transplantation: a multivariate analysis 167
Effects of prolonged exposure to pancreatic glucagon on the function, antigenicity and survival of isolated human islets 167
Hepatocyte grafting as an alternative to liver transplant 165
An unusual complication of percutaneous catheterization of the internal jugular vein 165
Proton magnetic resonance spectroscopy in renal transplant patients 164
Effects of monensin on insulin release from isolated human islets 163
Urinary excretion rates of multiple renal indicators after kidney transplantation: clinical significance for early graft outcome 162
Risk factors for cardiovascular disease in patients with functioning kidney grafts 162
Fate of kidneys retrieved from the same donor and grafted into different recipients: do donor related factors influence the graft outcome? 162
Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure 160
Bovine to porcine intrathymic islet xenotransplantation 159
Warren's operation in emergency:limits and indications. Value of the coronaro-spleno-renal decompression 158
The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose 158
Peripheral benzodiazepine receptors in isolated human pancreatic-islets 156
Regional vs. national renal sharing organizations: pros and cons 156
Utilizzazione di una associazione antibiotica e coagulante nella chirurgia della mammella 155
Tacrolimus-Based, Steroid-Free Regimens in Renal Transplantation: 3-Year Follow-up of the ATLAS Trial 155
Double-therapy vs Triple-therapy immunosuppression in cadaveric renal transplants 153
A multicenter randomized open-label study to evaluate the effects of early Cyclosporine withdrawal versus reduction in de novo renal transplant patients receiving Sirolimus, Cyclosporine, Steroids and Basiliximab induction. Interim analysis at three months. 153
Surgical endarterectomy for suprarenal iliac artery stenosis in renal allograft recipient 153
Long-Term Function of Kidneys From an Acute Renal Failure Donor on Continuous Venovenous Hemofiltration: A Case Report 153
Explant of one graft due to technical complications in dual kidney transplants: analysis of the long-term function of the remaining kidney 151
Exposure-Response Analysis of Everolimus with Reduced Cyclosporine in Renal Transplant Recipients at 24 Months in a Randomized Trial. 150
Suramin as an Anticomplementary Agent in Xenotransplantation 148
Peripheral Benzodiazepine receptors in isolated human pancreatic islets 148
Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure 147
Effects of corticotropin-releasing hormone on cytokine release from human lymphomononuclear cells or lymphocytes in response to xenogeneic pancreatic islets 145
Two corticosteroid-free regimens tacrolimus monotherpapy after basiliximab administration and tacrolimus/mycophenolatemofetil in comparison with a standard triple regimen in renal transplatation: results of the Atlas study 144
Totale 19.868
Categoria #
all - tutte 97.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.842 0 249 88 282 57 50 65 112 90 224 160 465
2022/20233.449 230 152 410 526 393 761 38 291 391 38 147 72
2023/20241.926 110 57 131 53 52 589 646 69 3 26 16 174
2024/20253.917 68 259 302 224 406 142 82 266 317 183 417 1.251
2025/20269.145 761 1.549 894 784 1.457 416 1.021 361 287 454 192 969
2026/2027918 636 282 0 0 0 0 0 0 0 0 0 0
Totale 31.591